PRIMECAP MANAGEMENT CO/CA/ 13D and 13G filings for Wave Life Sciences Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-08 11:50 am Sale | 2022-11-30 | 13G | Wave Life Sciences Ltd. WVE | PRIMECAP MANAGEMENT CO/CA/ | 4,225,908 4.860% | -368,667 (-8.02%) | Filing |
| 2022-02-10 12:29 pm Purchase | 2021-12-31 | 13G | Wave Life Sciences Ltd. WVE | PRIMECAP MANAGEMENT CO/CA/ | 4,594,575 7.810% | 670,100 (+17.07%) | Filing |
| 2021-02-12 12:02 pm Purchase | 2009-02-28 | 13G | Wave Life Sciences Ltd. WVE | PRIMECAP MANAGEMENT CO/CA/ | 3,924,475 8.050% | 3,924,475 (New Position) | Filing |